AUAUniversity

American Urological Association
  • ٤٫٤ (٣٤)
  • تعليم
  • يتم التحديث أسبوعيًا
AUAUniversity

The AUAUniversity podcast is an official podcast of the American Urological Association. More information can be found at https://auau.auanet.org

  1. قبل يوم واحد

    AUA2024: Ramon Guiteras Lecture

    AUA2024: Ramon Guiteras Lecture: Modern Innovation: Promise or Peril? Presenter: Craig Niederberger, MD, FACS

    ٢٤ من الدقائق

  2. ٩ جمادى الأولى

    AUA Leadership and Business Podcast: Urology Practice Manage - Overcoming Operational Challenges

    AUA Leadership and Business Podcast: Urology Practice Manage - Overcoming Operational Challenges This episode is brought to you by the AUA Leadership and Business Podcast, where urologic professionals experience the practical application of business acumen essential to successfully navigating today’s rapidly changing business environment! Subscribe today via your favorite podcast app.

    ٣٦ من الدقائق

  3. ٢٠ ربيع الآخر

    Focal Therapy Options for Prostate Cancer

    Focal Therapy Options for Prostate Cancer AUA Urology Core Curriculum: auau.auanet.org/core Host: Jay D. Raman, MD, FACS, FRCS(Glasg) Guest: Ruben Olivares, MD Outline: Segment 1: Why Focal Therapy? Segment 2: Patient selection for Focal Therapy Segment 3: Review of Existing Focal Therapy Modalities Segment 4: How to Build a Successful Focal Therapy Program

    ٣٧ من الدقائق

  4. ١٣ ربيع الآخر

    Hereditary Kidney Cancer Syndromes

    Hereditary Kidney Cancer Syndromes CME Available: https://auau.auanet.org/node/41772 ACKNOWLEDGEMENTS: Support provided by an independent educational grant from:  Merck & Co., Inc.  LEARNING OBJECTIVES: At the conclusion of this activity, participants should be able to: 1. Select patients who should undergo genetic testing to identify hereditary kidney cancer syndromes based on appropriate criteria, including family history and clinical presentation. 2. Implement strategies to address ethical concerns related to genetic testing, such as patient consent, confidentiality, and the potential impact on family members. 3. Discuss VHL syndrome, including its genetic basis, inheritance pattern, and associated tumors. 4. Properly diagnose and manage VHL syndrome in clinical practice based on knowledge of novel therapeutic strategies. 5. Utilize a multidisciplinary approach consisting of urologists, oncologists, geneticists and nephrologists when managing hereditary kidney cancer syndromes.

    ٣٩ من الدقائق

  5. ٢٩ ربيع الأول

    Prostate Cancer Update (2024): Expert Guidance for Urologists

    Prostate Cancer Update (2024): Expert Guidance for Urologists CME Available: https://auau.auanet.org/node/41868 Acknowledgements Support provided by independent educational grants from: Astellas Lantheus Medical Imaging Novartis Pharmaceuticals Corporation Pfizer, Inc. Learning Objectives At the conclusion of this activity, the learner will: 1. Align their practice with current AUA Guidelines (and recent amendments) pertaining to Screening, Diagnosis, and Management of Prostate Cancer. 2. Determine appropriate use of biomarker testing as it relates to diagnosis and therapy. 3. Analyze the role of imaging and types of imaging that aid in staging patients with prostate cancer. 4. Implement appropriate treatment paradigms for metastatic prostate cancer including treatment intensification. 5. Discuss the role of genetic and molecular profiling in the personalization of prostate cancer treatment plans.

    ١ س ١٩ د

  6. ٢٧ ربيع الأول

    Treatment Intensification in Metastatic HSPC

    Treatment Intensification in Metastatic HSPC CME Available: https://auau.auanet.org/node/41733 ACKNOWLEDGEMENTS: Support provided by independent educational grants from:  Lantheus Medical Imaging Novartis Pharmaceuticals Corporation LEARNING OBJECTIVES: At the conclusion of this activity, participants will be able to: 1. Explain the rationale behind treatment intensification in metastatic hormone sensitive prostate cancer (mHSPC), based on its pathophysiology.  2. Analyze the rationale and clinical evidence supporting treatment intensification in mHSPC, including potential benefits and risks.  3. Select appropriate patients for treatment intensification, considering factors such as disease burden, patient comorbidities, and individual risk profiles.

    ٤١ من الدقائق

  7. ٢٤ ربيع الأول

    Appropriate Use of Genetic Testing (who, what, when and how?)

    Appropriate Use of Genetic Testing (who, what, when and how?) CME Available: https://auau.auanet.org/node/41734 ACKNOWLEDGEMENTS: Support provided by independent educational grants from:  Lantheus Medical Imaging Novartis Pharmaceuticals Corporation LEARNING OBJECTIVES: At the conclusion of this activity, participants will be able to: 1. Identify the patient populations that should be considered for genetic testing in prostate cancer, based on family history, personal risk factors, and clinical indications. 2. Integrate genetic testing into clinical practice for prostate cancer, including developing workflows, referral processes, and multidisciplinary collaboration. 3. Utilize genetic test results to inform personalized treatment plans for prostate cancer patients, including targeted therapies and risk reducing strategies.

    ٣٨ من الدقائق

  8. ٢٢ ربيع الأول

    Sequencing Of Agents

    Sequencing Of Agents CME Available: https://auau.auanet.org/node/41735 ACKNOWLEDGEMENTS: Support provided by independent educational grants from: Lantheus Medical Imaging Novartis Pharmaceuticals Corporation LEARNING OBJECTIVES: At the conclusion of this activity, participants will be able to: 1. Review the latest evidence and clinical guidelines that inform the sequencing of therapeutic agents in metastatic prostate cancer, including data from key clinical trials. 3. Implement strategies for managing and overcoming resistance to therapy in metastatic prostate cancer, considering the role of sequencing in delaying resistance. 4. Apply best practices for monitoring treatment response and disease progression in patients undergoing therapy, and adjust sequencing strategies based on these observations.

    ٣٣ من الدقائق
مشاهدة الكل (٣٦١)

٤٫٤
من ٥
‫٣٤ من التقييمات‬

حول

The AUAUniversity podcast is an official podcast of the American Urological Association. More information can be found at https://auau.auanet.org

المعلومات

  • صناع العمل
    American Urological Association
  • سنوات النشاط
    ١٤٣٧ هـ - ١٤٤٦ هـ
  • الحلقات
    ٣٦١
  • التقييم
    ملائم
  • حقوق النشر
    © All rights reserved
  • موقع البرنامج على الويب
    AUAUniversity

قد يعجبك أيضًا

للاستماع إلى حلقات ذات محتوى فاضح، قم بتسجيل الدخول.

اطلع على آخر مستجدات هذا البرنامج

قم بتسجيل الدخول أو التسجيل لمتابعة البرامج وحفظ الحلقات والحصول على آخر التحديثات.
تحديد بلد أو منطقة

أفريقيا والشرق الأوسط، والهند

آسيا والمحيط الهادئ

أوروبا

أمريكا اللاتينية والكاريبي

الولايات المتحدة وكندا